Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.

Brandes AA, Rigon A, Zampieri P, Ermani M, Carollo C, Altavilla G, Turazzi S, Chierichetti F, Florentino MV.

Cancer. 1998 Jan 15;82(2):355-61.

PMID:
9445194
2.

Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.

Brandes AA, Rigon A, Zampieri P, Scelzi E, Amistà P, Berti F, Rotilio A, Gardiman M, Fiorentino MV.

J Neurooncol. 1996 Dec;30(3):247-55.

PMID:
8943100
3.

Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme.

Mañé JM, Fernández R, Muñoz A, Rubio I, Ferreiro J, López-Argumedo G, Barceló R, López-Vivanco G.

Tumori. 2004 Nov-Dec;90(6):562-6.

PMID:
15762357
4.

Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study.

Lassen U, Kristjansen PE, Wagner A, Kosteljanetz M, Poulsen HS.

J Neurooncol. 1999 Jun;43(2):161-6. Erratum in: J Neurooncol. 2003 May;62(3):361.

PMID:
10533728
5.

Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.

Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):57-63.

PMID:
9422558
6.

Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.

Brandes AA, Scelzi E, Zampieri P, Rigon A, Rotilio A, Amista P, Berti F, Fiorentino MV.

Am J Clin Oncol. 1997 Aug;20(4):364-7.

PMID:
9256890
7.

Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.

Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A.

Anticancer Res. 2003 Nov-Dec;23(6D):5159-64.

PMID:
14981983
8.

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.

Weller M, Müller B, Koch R, Bamberg M, Krauseneck P; Neuro-Oncology Working Group of the German Cancer Society.

J Clin Oncol. 2003 Sep 1;21(17):3276-84.

PMID:
12947063
9.

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.

BMC Cancer. 2006 Oct 18;6:247.

10.

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.

Affronti ML, Heery CR, Herndon JE 2nd, Rich JN, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman HS.

Cancer. 2009 Aug 1;115(15):3501-11. doi: 10.1002/cncr.24398.

11.

Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide.

Donato V, Papaleo A, Castrichino A, Banelli E, Giangaspero F, Salvati M, Delfini R.

Tumori. 2007 May-Jun;93(3):248-56.

12.

Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.

Jeremic B, Shibamoto Y, Grujicic D, Stojanovic M, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J.

J Neurooncol. 2001 Jan;51(2):133-41.

PMID:
11386410
14.

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.

Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J, Page M, Malec M, Davis RL, Gutin PH, Lamborn K, Wilson CB, Phillips TL, Larson DA.

Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):71-7.

PMID:
11163499
15.

Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme.

Barrié M, Couprie C, Dufour H, Figarella-Branger D, Muracciole X, Hoang-Xuan K, Braguer D, Martin PM, Peragut JC, Grisoli F, Chinot O.

Ann Oncol. 2005 Jul;16(7):1177-84. Epub 2005 Apr 27.

16.

A multidrug combination designed for reversing resistance to BCNU in glioblastoma multiforme.

Brandes AA, Turazzi S, Basso U, Pasetto LM, Guglielmi B, Volpin L, Iuzzolino P, Amistà P, Pinna G, Scienza R, Ermani M.

Neurology. 2002 Jun 25;58(12):1759-64.

PMID:
12084873
17.

Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center.

Fazeny-Dörner B, Gyries A, Rössler K, Ungersböck K, Czech T, Budinsky A, Killer M, Dieckmann K, Piribauer M, Baumgartner G, Prayer D, Veitl M, Muhm M, Marosi C.

Wien Klin Wochenschr. 2003 Jun 24;115(11):389-97.

PMID:
12879737
18.

Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.

Buckner JC, Ballman KV, Michalak JC, Burton GV, Cascino TL, Schomberg PJ, Hawkins RB, Scheithauer BW, Sandler HM, Marks RS, O'Fallon JR; North Central Cancer Treatment Group 93-72-52; Southwest Oncology Group 9503 Trials.

J Clin Oncol. 2006 Aug 20;24(24):3871-9.

19.

Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.

Hainsworth JD, Ervin T, Friedman E, Priego V, Murphy PB, Clark BL, Lamar RE.

Cancer. 2010 Aug 1;116(15):3663-9. doi: 10.1002/cncr.25275.

20.

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.

Bock HC, Puchner MJ, Lohmann F, Schütze M, Koll S, Ketter R, Buchalla R, Rainov N, Kantelhardt SR, Rohde V, Giese A.

Neurosurg Rev. 2010 Oct;33(4):441-9. doi: 10.1007/s10143-010-0280-7. Epub 2010 Aug 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk